ArticleTargeted oncology2026

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.

Silvia Camera et al.PubMed ↗Publisher ↗

No numbers read from the abstract.